Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development
- 1 October 2006
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 42 (4), 455-463
- https://doi.org/10.1016/j.jpba.2006.05.008
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodiesDrug Development Research, 2004
- Human IgG2 Can Form Covalent DimersPublished by The American Association of Immunologists ,2003
- Monoclonal antibodies as therapeutics in oncologyCurrent Opinion in Biotechnology, 2002
- Monoclonal antibodies in immune and inflammatory diseasesCurrent Opinion in Biotechnology, 2002
- Identification of multiple sources of charge heterogeneity in a recombinant antibodyJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Schistosoma japonicum cathepsin D aspartic protease cleaves human IgG and other serum componentsParasitology, 2001
- Fasciola hepatica: Parasite-Secreted Proteinases Degrade All Human IgG Subclasses: Determination of the Specific Cleavage Sites and Identification of the Immunoglobulin Fragments ProducedExperimental Parasitology, 2000
- Interheavy disulfide bridge in immunoglobulin G (IgG) reacting with dithionitrobenzoate: A unique feature in serum proteinsJournal of Biochemical and Biophysical Methods, 1997
- The application of tert-butylhydroperoxide oxidation to study sites of potential methionine oxidation in a recombinant antibodyTechniques in Protein Chemistry, 1996
- THE GLUTAMIC ACID-PYRROLIDONECARBOXYLIC ACID SYSTEMPublished by Elsevier BV ,1937